Literature DB >> 21821472

Thrombus aspiration alone: a potential strategy in ST elevation myocardial infarction intervention.

Fei Chong1, Nicholas Cox, Yean Lim.   

Abstract

We are reporting a case of 46 year-old man, smoker with strong family history of coronary artery disease, presenting with acute anterolateral ST elevation myocardial infarction (STEMI). Diagnostic angiography revealed thrombus at the distal left main, occluding the anterior descending and intermediate arteries. Thrombus aspiration was performed with successful return of flow in the left coronary system. Stenting was deferred due to absence of occlusive lesion. He was commenced on glycoprotein (GP) IIbIIIa inhibitor and received intra-aortic balloon pulsation for haemodynamic support. Follow-up angiography revealed good flow in left coronary artery with normal ventricular function and no significant disease. He remained event-free at one-year follow-up. This case demonstrated that in the absence of occlusive lesion, thrombus aspiration alone without angioplasty or stenting is safe and effective with good clinical outcome.
Copyright © 2011 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821472     DOI: 10.1016/j.hlc.2011.07.005

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  2 in total

1.  Thrombus Entrapment in the Hemostasis Valve during Thrombus Aspiration: An Octogenarian with Inferior Myocardial Infarction and Complete Flow Restoration without Any Additional Angioplasty.

Authors:  Nurdan Papila Topal; Altug Cincin; Murat Sunbul; Kursat Tigen; Ibrahim Sari
Journal:  Int J Angiol       Date:  2013-09

2.  A new technique to salvage myocardium following the failure of thrombus aspiration in acute myocardial infarction: a case report.

Authors:  Daoyuan Si; Guohui Liu; Yaliang Tong; Cheng Zhang; Yuquan He
Journal:  BMC Cardiovasc Disord       Date:  2018-12-10       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.